Renalytix plc (RNLX) Financials

RNLX Assets vs Liabilities

DateAssetsLiabilities
March 31, 2024 8.8 million 19.9 million
Dec. 31, 2023 11.3 million 19.2 million
Sept. 30, 2023 19.5 million 21.0 million
June 30, 2023 30.6 million 23.7 million

RNLX Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2024 -4.9 million 671000
Dec. 31, 2023 -7.9 million 97000
Sept. 30, 2023 -9.5 million 523000
June 30, 2023 -8.6 million 574000

RNLX Net Income

No data available :(

RNLX Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2024 4.7 million 4.9 million 78000
Dec. 31, 2023 5.6 million 5.3 million 118000
Sept. 30, 2023 13.9 million 5.9 million 141000
June 30, 2023 24.7 million 7.5 million 171000

RNLX Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2024 48.8 million
Dec. 31, 2023 48.6 million
Sept. 30, 2023 47.4 million
June 30, 2023 93.8 million

RNLX Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2024 3000 2.2 million 3.9 million -3.2 million
Dec. 31, 2023 - 3.2 million 5.3 million 3.1 million
Sept. 30, 2023 - 2.8 million 6.1 million -
June 30, 2023 - 3.3 million 6.5 million -

RNLX Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2024 535000 601000
Dec. 31, 2023 709000 480000
Sept. 30, 2023 459000 502000
June 30, 2023 518000 673000

RNLX Revenue by Segment

Graph available only for paid members. Upgrade to see it.

RNLX

Price: $0.21

52 week price:
0.18
2.40

Earnings Per Share: -0.62 USD

Exchange: NCM

Sector: Healthcare

Industry: Health Information Services

Country: United States

Volume: 137500

Market Capitalization: 17.9 million

Links: